Isohelix™ Scores a Second Chinese CFDA Registration

Isohelix™ Scores a Second Chinese CFDA Registration

The registration process included rigorous and exhaustive checks, covering risk analysis, manufacturing specifications, technical product performance and quality control processes.

best

Tom Hole, CEO of Isohelix comments that “Isohelix has been well established in the marketplace for some time, and the registration of both of these key product lines supports the quality of our product design, manufacture and ongoing development.”

Isohelix manufactures DNA and RNA Collection devices for Saliva and Buccal Cells, together with kits for stabilization and extraction of high purity DNA for research and medical purposes.